Sowell Financial Services LLC Acadia Pharmaceuticals Inc Transaction History

Sowell Financial Services LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$19.4 - $27.42 $57,482 - $81,245	-2,963 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$25.02 - $54.99 $8,706 - $19,136	348 Added 13.31%	2,963 $62,000
Q4 2020 Jan 13, 2021	BUY	$41.04 - $56.79 $33,037 - $45,715	805 Added 44.48%	2,615 $140,000
Q3 2020 Nov 12, 2020	SELL	$36.42 - $57.0 $29,536 - $46,227	-811 Reduced 30.94%	1,810 $75,000
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $34,038 - $45,716	867 Added 49.43%	2,621 $127,000
Q1 2020 May 12, 2020	BUY	$31.65 - $46.87 $8,165 - $12,092	258 Added 17.25%	1,754 $74,000
Q4 2019 Feb 07, 2020	BUY	$36.21 - $51.4 $54,170 - $76,894	1,496 New	1,496 $0

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.62B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.